Health Resources and Services Administration
Rural Communities Opioid Response Program (RCORP)-Impact
About This Grant
The Rural Communities Opioid Response Program (RCORP)–Impact funds rural communities to drive measurable improvements in access to integrated, coordinated treatment and recovery services for substance use disorder (SUD), including opioid use disorder (OUD). Its long-term aim is to reduce morbidity and mortality associated with SUD and enable sustained recovery and well-being. The program supports: New or expanded evidence-based SUD prevention, treatment, and recovery services in rural areas; Coordination across health and supportive social services to enable sustained, long-term recovery; A larger, more responsive workforce to address SUD-related needs; and Multi-sector community networks to strengthen and sustain local service delivery. The focus of RCORP-Impact is on reducing the impact of opioid misuse on rural America. However, HRSA recognizes that people who misuse opioids often struggle with other substances as well, including alcohol. Therefore, RCORP-Impact supports a comprehensive approach to address all SUD, including OUD, within a continuum of mental, behavioral, and related social supports.
Who Can Apply
Focus Areas
Additional Details
- CFDA / ALN Number
- 93.912
- Program Title
- Rural Healthcare Services Programs
- Expected Awards
- 80
- Estimated Total Funding
- Up to $60M
- Source
- Grants.gov · View original listing
Similar Grants
Center for Medicare and Medicaid Services
Make America Healthy Again – Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence
Up to $3.3MDue in 7 days — May 15, 2026Centers for Disease Control and Prevention - ERA
Occupational Safety and Health Education and Research Centers (T42)
$4.5M – $9MDue October 26, 2028National Institutes of Health
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
Due May 8, 2027National Institutes of Health
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
Due June 1, 2027National Institutes of Health
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Due November 18, 2026National Institutes of Health
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
Due January 7, 2028